Corporate ActionMay 13, 2026, 04:42 PM
Outlook Therapeutics to Sell Up to $100M Common Stock via ATM Offering
AI Summary
Outlook Therapeutics, Inc. entered into a new At The Market (ATM) Offering Agreement with H.C. Wainwright & Co., LLC, allowing the company to sell up to $100,000,000 of its common stock. This new agreement replaces a prior ATM sales agreement with BTIG, LLC, which was terminated effective May 12, 2026. Additionally, the company reported preliminary unaudited cash and cash equivalents of approximately $7.7 million as of March 31, 2026, which does not include $4.5 million in net proceeds from a separate registered direct equity offering completed in April 2026.
Key Highlights
- Outlook Therapeutics entered an At The Market (ATM) Offering Agreement for up to $100,000,000 of common stock.
- H.C. Wainwright & Co., LLC will act as sales agent and/or principal for the offering.
- The company will pay H.C. Wainwright a commission equal to 3% of aggregate gross proceeds.
- The prior ATM sales agreement with BTIG, LLC for up to $100,000,000 was terminated.
- Preliminary cash and cash equivalents were approximately $7.7 million as of March 31, 2026.
- This cash balance excludes $4.5 million net proceeds from an April 2026 equity offering.